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Atomic Layer Deposition of a Silver Nanolayer on Advanced 
Titanium Orthopedic Implants Inhibits Bacterial Colonization 
and Supports Vascularized de Novo Bone Ingrowth
Aine Devlin-Mullin, Naomi M. Todd, Zahra Golrokhi, Hua Geng, Moritz A. Konerding, 
Nigel G. Ternan, John A. Hunt, Richard J. Potter, Chris Sutcliffe, Eric Jones, Peter D. Lee, 
and Christopher A. Mitchell*
DOI: 10.1002/adhm.201700033
Joint replacement surgery is associated with significant morbidity and 
mortality following infection with either methicillin-resistant Staphylococcus 
aureus (MRSA) or Staphylococcus epidermidis. These organisms have strong 
biofilm-forming capability in deep wounds and on prosthetic surfaces, with 
103–104 microbes resulting in clinically significant infections. To inhibit 
biofilm formation, we developed 3D titanium structures using selective laser 
melting and then coated them with a silver nanolayer using atomic layer 
deposition. On bare titanium scaffolds, S. epidermidis growth was slow but 
on silver-coated implants there were significant further reductions in both 
bacterial recovery (p < 0.0001) and biofilm formation (p < 0.001). MRSA 
growth was similarly slow on bare titanium scaffolds and not further affected 
by silver coating. Ultrastructural examination and viability assays using either 
human bone or endothelial cells, demonstrated strong adherence and growth 
on titanium-only or silver-coated implants. Histological, X-ray computed 
microtomographic, and ultrastructural analyses revealed that silver-coated 
titanium scaffolds implanted into 2.5 mm defects in rat tibia promoted robust 
vascularization and conspicuous bone ingrowth. We conclude that nanolayer 
silver of titanium implants significantly reduces pathogenic biofilm formation 
in vitro, facilitates vascularization and osseointegration in vivo making this a 
promising technique for clinical orthopedic applications.
1. Introduction
Total hip replacements (THR) gener-
ally have an excellent clinical outcome; 
however, perioperative infection rates fol-
lowing this procedure range from 0.5% 
to 2%[1] and with over 62 000 of these 
surgeries performed each year in the UK 
(National Joint Registry, 2014) there is an 
urgent clinical need to reduce biofilm for-
mation on the surface of materials used 
in these devices. THR infection usually 
results in two additional surgical proce-
dures: one to remove the implant and 
eradicate the infection followed by an 
additional THR. This treatment puts a sig-
nificant burden on the patient and health 
service resources, as revision surgery can 
be up to three to four times the cost of 
the initial THR.[2] There are several risk 
factors, which can increase the possibility 
of implant related infection, including 
increased operative time,[3] comorbidities, 
and a prior history of a joint arthroplasty.[4]
Infections following THR can be caused 
by very low numbers (103–104) of osteolytic 
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microorganisms and are mainly attributable to coagulase nega-
tive staphylococci, Gram-negative rod-shaped bacteria, and 
streptococci.[1,4] Implant-related infections are caused by micro-
organisms, which colonize and form biofilms on the implant 
surface, and infection occurs in three main ways: microbial col-
onization at the time of implantation; hematogenous spreading 
of the pathogen to the implant; or via direct spreading from 
an adjacent infection.[5] When microbial pathogens adhere 
to the implant they form a complex biofilm, which provides 
protection for the constituent organisms from both the host’s 
immune system and from the penetration of antibiotics.[6] The 
process of colonization of an implant is described as a “race for 
the surface” between the host cells, bone extra cellular matrix, 
and the microbial pathogen.[7]
With the onset of an osteolytic infection, there are many 
problems for the patient: including primarily, pain, increased 
risk of hospitalization, additional surgical procedures, and 
poor functional outcome.[8] Treatment options will depend on 
the health of the patient, the extent of the infection, debride-
ment of infected tissue around the joint, and retention of a 
well fixed prosthesis. The two main treatment options are: 
one-stage revision surgery, consisting of the removal of the 
prosthesis, infected tissue and cement with reimplantation of 
a new prosthesis; or alternatively, two-stage revision surgery, 
where reimplantation of the prosthesis is delayed for 6–8 weeks 
and antibiotic eluting cement spacers are used to combat infec-
tion. Bone cements loaded with antibiotics are still in use but 
the extensive use of gentamicin as well as increasing antibi-
otic resistance means further infection prevention measures 
are required to lower the incidence of clinically relevant peri-
operative hip infections.[9,10] Two-stage revisions are the most 
common approach to treat chronic prosthetic joint infections in 
many hospitals, but in severe cases where the patient is unsuit-
able for surgery and antibiotics are not effective, hip disarticula-
tion may be considered.[11]
Titanium is a commonly used material for orthopedic 
applications and additive manufacturing techniques are now 
widely used[12] to create the complex geometries required for 
orthopedic applications such as THR. In addition to com-
plex geometry, the surfaces of these titanium structures have 
the potential for modification by a variety of methodologies, 
including introduction of biomimetic molecules[13,14] and ani-
onic plasma chemical approaches.[15] These techniques can 
introduce surface modifications that enhance biocompat-
ibility[14] and improve biomechanical properties[12] or decrease 
bacterial adhesion[16] and growth, thus reducing the potential 
for infection.[17] The prevention of osteolytic infections is a high 
priority in the field of orthopedic research and has been widely 
explored with approaches including the coating of titanium 
implants with various metallic and organic compounds, and 
impregnation of bone cement with silver[18] or antibiotics.[19] 
The use of silver as an antimicrobial agent dates to around 
4000BC in ancient Egypt[20] and it is still used today as a micro-
bicide as it kills a broad range of microorganisms,[21] although 
in vitro resistance in Escherichia coli and has been noted in 
organisms with metal ion-transport pump deficiencies.[22] Silver 
coatings have previously been used in the field of orthopedics 
on a variety of implantable devices such as catheters, where 
they have been shown to reduce bacterial associated urinary 
tract infections.[23,24] In the past, polymethyl methacrylate bone 
cement was loaded with silver but this was found to cause 
serious side effects. In human trials, neurological deficits and 
muscle paralysis due to the silver accumulation within the cen-
tral nervous system were observed.[18]
As the therapeutic range of silver is relatively narrow, it 
is critical to minimize the amount of silver in order to pre-
vent cytotoxicity while still retaining sufficient antibacterial 
activity.[25] Therefore, we sought to develop orthopedic implants 
with ultrathin nanosilver coatings that exhibit none of this 
cytotoxicity while at the same time maintaining a high effec-
tiveness against multidrug-resistant bacteria.[9] Others have 
previously reported on the use of nanosilver coatings and while 
some report positive antimicrobial results, there often remains 
a significant disconnect between the science and the “real 
world” manufacturability of coated implants. Techniques such 
as plasma immersion ion implantation[26] have been used to 
embed silver-nanoparticles into titanium and show that these 
modified surfaces are highly effective in inhibiting Staphylo-
coccus aureus and E. coli strains while promoting in vitro prolif-
eration of osteoblast-like cells.
While plasma-based surface treatments are readily applied to 
flat substrates, they are often limited to line-of-sight treatments 
as plasma species decay over time, particularly as they interact 
with surfaces. As with plasma-based processes, physical vapor 
deposition (including evaporation, sputtering, pulsed laser 
deposition, and molecular beam epitaxy) processes also suffer 
from line-of-sight limitations, which limits their usefulness 
for coating the complex 3D geometries associated with porous 
orthopedic implants. In the current study, we use atomic layer 
deposition (ALD) to produce ultrathin, highly conformal silver 
films on 3D bone-like titanium implants.
ALD is an adaptation of chemical vapor deposition, which 
uses self-limiting surface reactions that offer a number of 
key benefits over many of the other coating methods avail-
able. These benefits include subangstrom thickness control, 
which is controlled “digitally” using the number of ALD cycles, 
extremely high conformality (even on very high aspect ratio 3D 
structures), batch processing compatibility so that large num-
bers of different shape and size implants can potentially be 
coated simultaneously and highly repeatable processing con-
trol. Therefore, ALD is capable of yielding a uniform deposi-
tion[27] of silver on complex structures such as the foams and 
solids described in this study.[28]
The technological development of the selective laser melting 
(SLM) technique[29] allows production of functionally graded 
parts for orthopedic applications. SLM enables titanium ortho-
pedic implants to be generated with intricate geometries, where 
solid and porous structures are contiguous. Porous structures 
with optimized pore sizes in the range of 100–700 µm are 
required to encourage bone ingrowth into certain areas, while 
solid components provide greater biomechanical strength for 
the bony attachment of the prosthesis. In order to reduce the 
potential for silver toxicity while maintaining bactericidal prop-
erties of the surface of SLM manufactured implants, we coated 
our titanium structures with a nanolayer of metallic silver using 
ALD.
When examining the biological properties of surface layering 
of titanium with silver or silver composites, the bactericidal 
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potential in conjunction with its in vitro[30] and/or in vivo 
[reviewed in ref. [31]] abilities to facilitate bone growth is rarely 
investigated[14]; this makes the assessment of the potential 
clinical applications for these coating techniques problem-
atic. Therefore, the purpose of our unique biological investi-
gations was threefold: to determine the microbicidal effect of 
a conformal-nanolayer ALD-deposited silver on implants in 
the presence of clinically relevant osteolytic bacterial strains 
(Staphylococcus epidermidis ATCC 35983 and methicillin-
resistant Staphylococcus aureus (MRSA) ATCC 43300): to inves-
tigate the influence of surface modification on cell growth in 
vitro and, most critically, to confirm that the new blood vessels, 
which ensure tissue survival, grow within the regenerated bone.
2. Results
2.1. Production of Ti-Only or Ti/Ag Scaffolds for 
In Vitro and In Vivo Studies
Ultrastructural examination of the samples revealed uniform 
solid (Figure 1a,c) and 30° randomized tetrahedral foam scaf-
folds (Figure 1b,d) characterized by a roughened surface 
topology, with varying numbers of 30–50 µm diameter nodules 
(incipiently melted Ti powder) on their surfaces. Low mag-
nification ultrastructural examination revealed that surface 
topology of the Ti samples is smooth (Figure 1a,b), whereas the 
surface morphology of Ti–Ag scaffolds (Figure 1c,d) exhibited a 
grainy texture.
2.2. Characterization of Nanolayer Silver Surface 
Coating of Titanium
Self-limiting ALD growth conditions for the silver process 
were established prior to the current work and are reported 
elsewhere.[28] As with other ALD processes, under self-limiting 
conditions, the total mass deposition increases in a linear 
fashion with ALD cycles (Figure 2a). There appears to be a 
slight deviation from this for low numbers of cycles, which 
is attributed to the nucleation of the growth. If the films are 
assumed to be planar with a density equal to the bulk value of 
silver (10.49 g cm−3), then the mass deposition after 500 cycles 
would equate to film thickness of ≈13 nm. The X-ray diffraction 
(XRD) pattern (Figure 2b) of ALD silver deposited on Si(100) 
shows reflections at 2θ values of 38.2° and 44.4°, which are con-
sistent with the (111) and (200) features of metallic silver with 
the (Fm-3m) space group (JCPDS 04-0783).
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Figure 1. Two types of structures: solid (left panel: a & c) or 30° randomized tetrahedral foams (right panels; b & d) were generated by SLM followed 
by sintering. Approximately half the samples were used as Ti-only controls (top panel; a & b) or titanium coated with a nanolayer of silver (bottom 
panel; c & d). For microbiological and cell culture studies solid samples were used, whereas foam samples were used for in vivo studies to facilitate 
ingrowth of regenerating bone into the porous structure.
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Scanning electron microscopy (SEM) analysis of the silver 
films deposited on titanium (Figure 2c) reveals that the films are 
textured at the nanoscale. For films deposited using 500 cycles, 
the nanoparticles tend to be nonsymmetrical and vary in size 
between ≈40 and ≈90 nm. More detailed studies, which will 
not be reported here, show that growth proceeds by a process of 
nucleation and growth of uniformly sized hemispherical nano-
particles. However, as the nanoparticles grow with increasing 
numbers of ALD cycles, individual nanoparticles merge together 
to form irregular nanostructures. Energy-dispersive X-ray 
(EDX) of the films (Figure 2d) shows two clear peaks at ≈3 and 
≈4.5 keV, which correspond to the Lα-emission line of silver and 
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Adv. Healthcare Mater. 2017, 1700033
www.advancedsciencenews.com
Figure 2. Growth and physicochemical characterization of ALD silver at 125 °C. Mass deposition per unit area as a) a function of ALD cycles performed 
at 125 °C on flat titanium foil. b) X-ray diffraction of ALD silver deposited at 125 °C with 500 ALD cycles on silicon. c) High-magnification SEM images 
reveals silver nanoparticles deposited on a titanium porous substrate. d) Energy-dispersive X-ray spectroscopic characteristic spectrum obtained for 
silver-nanoparticles deposited on titanium substrate; the observable peaks confirm the presence of silver and titanium in the sample. e) XPS spectrum 
of silver deposited on a flat titanium foil.
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Figure 3. a) Ultrastructural examination of a Ti-only sample, reveals a multilayered S. epidermidis biofilm resulting from incubation of 103 organisms 
for 96 h. Several water pores (black arrows) and threadlike appendages between organisms (arrowheads), both typical of biofilms are observed. On 
Ti/Ag solids b) the surface density of organisms is markedly reduced compared to Ti-only samples. Bars = 5 mm. Quantitative studies revealed a 
> 2-log reduction in c) c.f.u. numbers of S. epidermidis d) as well as reduced crystal violet elution in Ti/Ag samples when compared with Ti-only controls. 
Scanning electron microscopic examination of MRSA cultured for 96 h on either e) Ti-control or f) Ti/Ag scaffolds revealed relatively few organisms on 
the materials’ surfaces, although there is evidence of replication (arrows), in addition to deposition of mucoid-like matrix (arrowheads). No statistically 
significant differences in c.f.u. numbers were detected on either g) scaffold type, although there was a 2–3-log reduction in growth when compared to 
S. epidermidis cultures (cf. Figure c). There were also no differences in crystal violet quantitation (NS; p > 0.05) from MRSA cultures grown on h) either 
Ti-only or Ti/Ag scaffolds; although these values were much lower than those observed in S. epidermidis cultures (cf. Figure d). Graphs show a single 
representative data set (n = 6) from three independent experiments, with columns indicating mean ± SEM. Statistical significance was assessed with 
a student’s t-test; ***p < 0.001.
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kα-emission line of titanium, respectively. To confirm that the 
ALD does not leave behind precursor residue, X-ray photoelec-
tron spectroscopy (XPS) was carried out on a titanium witness 
sample (Figure 2e). Features relating to silver, titanium, carbon, 
and oxygen are visible, but no fluorine feature is observed (the 
F1s feature would be at ≈688.8 eV). The binding energies of 
the carbon and oxygen features are consistent with atmospheric 
surface absorbates such as water, carbon monoxide, and carbon 
dioxide.[28] The absence of a fluorine feature in the XPS pro-
vided evidence that the ALD reaction is clean and proceeds to 
completion.[28]
2.3. Growth of S. epidermidis and MRSA on Silver-Coated 
Titanium Structures
Bacterial adhesion and biofilm formation on both uncoated 
and silver-coated titanium structures were investigated by 
ultrastructural examination and determination of colony 
forming units (c.f.u.) of scaffolds seeded with ≈1 × 103 cells 
of either S. epidermidis (Figure 3a–d) or MRSA (Figure 3e–h) 
on their surfaces for 96 h. Ultrastructural features of S. epi-
dermidis biofilm formation on titanium scaffolds, included 
multilayered coccoid structures within a mucoid-like matrix 
containing water pores (Figure 3a), whereas Ti/Ag scaf-
folds had much fewer of these organisms on their surface 
and showed little evidence of biofilm formation at 96 h 
(Figure 3b). In addition, a 2-log reduction in the numbers 
of S. epidermidis organisms recovered from silver-coated tita-
nium solids (p < 0.001) was consistently observed (Figure 3c). 
Following solubilization of crystal violet (CV) (a quantitative 
measure of biofilm formation), solutions obtained from 
silver-coated titanium structures seeded with S. epider-
midis also had a significantly lower optical density (OD) 
when compared to uncoated samples (Figure 3d; p < 0.001). 
Growth of MRSA on either Ti-only samples (Figure 3e,g,h) 
was slow in comparison to that observed by S. epidermidis 
(cf. Figure 3a,c,d). However, early indications of biofilm for-
mation by MRSA were observed on both Ti-only and Ti/Ag 
scaffolds at 96 h (Figure 3e,f); although neither c.f.u. counts 
(Figure 3g) nor spectrophotometric measurements for ODof 
crystal violet staining of biofilms (Figure 3h) were signifi-
cantly different (NS; p > 0.05).
2.4. Human Cell Lines Attach and Grow on 
Silver-Coated Titanium Scaffolds
Ultrastructural analysis of a primary human osteogenic sar-
coma cells (SAOS-2) with osteoblast-like phenotype grown for 
48 h on either Ti-only (Figure 4a) or Ti/Ag (Figure 4b) scaffolds 
revealed that both implant types contained clusters of adherent 
cells with typically squamous morphology. Assays employing 
3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide 
(MTT) also confirmed that from 6 to 48 h SAOS-2 cell viability 
increased (p < 0.05; Figure 4c), although there were no statisti-
cally significant differences between growth on either Ti-only or 
Ti/Ag scaffolds (NS; p > 0.05). Following incubation for 48 h, 
human microvascular endothelial cells (HDMEC) with typical 
bipolar morphology and exhibiting filopodial and lamellipodial 
www.advhealthmat.de
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Figure 4. a–c) SAOS-2 osteosarcoma and d–f) HDMEC-1 endothelial cells grow on the surface of either Ti-only or Ti/Ag scaffolds. After 24 h of cul-
ture, SAOS-2 cells with characteristic squamous morphology were observed to be tightly adherent, closely apposed and found in clusters, particularly 
near the rim of solid scaffolds of both a) Ti-only and b) Ti/Ag samples. There was a gradual increase in cell viability of c) SAOS-2 cells from 6 to 48 h 
(p < 0.05) but no differences in viability between those seeded on either Ti or Ti/Ag scaffolds (NS; p > 0.05). HDMEC grown on the surface of either 
d) Ti-only or e) Ti/Ag scaffolds are typically found in small clusters, with some cells showing elongated lamellipodia spanning surface depressions 
(arrows). In HDMEC cultures, results from MTT assays indicated that there was a gradual increase in cell viability from 6 to 48 h (p < 0.05) but no 
statistically significant difference between OD575 values from Ti-only or Ti/Ag scaffolds (NS; p > 0.05).
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extensions were observed on either Ti (Figure 4d) or Ti/Ag 
scaffolds (Figure 4e). MTT assay analyses revealed that cell 
viability of surface associated with HDMEC cells also increased 
from 6 to 48 h (p < 0.05; Figure 4f), although there were no 
significant differences between the Ti and Ti/Ag groups (NS; 
p > 0.05).
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Figure 5. Robust bone and microvascular ingrowth is observed in both Ti-only and Ti/Ag foam scaffolds. Rat tibial subcritical size defects were 
implanted with either a,c,e) un-coated or b,d,f) Ti/Ag-coated foams and animals recovered from surgery for either a,b) 2, c,d) 6, or e,f) 12 weeks. Ani-
mals were then perfused with vascular casting resin, the tibiae dissected, the soft-tissue removed by desiccation and samples prepared for imaging by 
scanning electron microscopy. At 2 weeks in both a) Ti and b) Ti–Ag samples, there is new bone growth at the periphery and mineralized material on 
struts but relatively little new bone within the scaffold pores; robust ingrowth of larger caliber vessels (arrowheads) as well as capillaries is conspicuous 
around the struts (arrows). At the edge of the foams early bone ingrowth is evident (asterisk), while around the struts copious filamentous material 
and mineral deposition is seen. After 6 weeks in vivo, the foams were infiltrated with porous bone (asterisks) covered by a fibromatrix with dispersed 
crystalline mineral deposits. After 12 weeks e,f) in vivo, there was evidence of compact bone ingrowth (asterisks) into the pores of both e) Ti-only 
and f) Ti/Ag implants and microvascular architecture around the struts was more organized with fewer anastomoses (cf. 2 weeks). Volkmann canals 
(many with attending capillaries) were observed both at the edges of the implants as well as within the pore structures. Cracks on the specimens and 
separation of regenerated bone (particularly around struts) is an artifact of processing for SEM. PB, pre-existing bone; Sc, scaffold; asterisk, new bone 
growth; m, mineralized matrix.
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2.5. Detection of Free Ag by Inductively 
coupled plasma mass spectrometry (ICP-MS)
ICP-MS reading from samples of liver taken 
from animals implanted with either Ti-only 
or Ti/Ag-coated implants, resulted in read-
ings that were at or below the limit of detec-
tion (1 part per billion), indicating that there 
is no detectable Ag/Ag+ in these samples.
2.6. Vascular Corrosion Casting and Ultras-
tructural Analysis
Ultrastructural analyses of vascular corro-
sion casts from rat tibiae implanted with 
either Ti-only (Figure 5a,c,e) or Ti/Ag 
(Figure 5b,d,f) foam scaffolds revealed the 
relationship between pre-existing bone, as 
well as morphology of microvasculature at 
2 (Figure 5a,b), 6 (Figure 5c,d), and 12 weeks 
(Figure 5e,f) following surgery. At 2 weeks, 
the foam scaffolds were infiltrated at their 
edges with a highly porous bone matrix and 
a dense network of microvessels (particu-
larly around the struts) that originated from 
pre-existing bone surrounding the site of 
the defect (Figure 5a,b). Conspicuous min-
eralized material also encrusts the struts on 
the surface of Ti-only and Ti/Ag scaffolds 
at 2 weeks (Figure 5a,b). Ultrastructural 
examination of the surface of a 2 week Ti/Ag implant revealed 
hemitubular structures in various stages of development 
(Figure 6), which were characterized by concentric lamellae and 
contained mineralized, parallel-orientated fibril bundles (inset 
of Figure 6); features that are consistent with de novo Haver-
sian system formation. In 6 week samples, the gaps within 
scaffolds of both Ti-only and Ti/Ag foams contained numerous 
blood vessels interspersed with porous bone or partially ossi-
fied fibrous material (Figure 5c,d). Ultrastructural analyses of 
vascular casts from rat tibia harvested at 12 weeks following 
implantation with Ti-only or Ti/Ag foams showed that implants 
were infiltrated with bone containing Volkmann canals with 
attendant microvessels (Figure 5e,f). Microvessel morphology 
from tibiae implanted with Ti-only or Ti/Ag scaffolds and har-
vested at 12 weeks were more regular, smooth and had fewer 
anastomoses with neighboring vessels than those observed in 2 
week samples (cf. Figure 5e,f with Figure 5a,b).
2.7. Histology
Light microscopic examination of thick (50–100 µm) sections 
from rat tibiae sampled at 2 weeks post-implantation revealed 
infiltration of porous woven bone at the edges and core of both 
Ti-only (Figure 7a) and Ti/Ag scaffolds (Figure 7b). By 12 weeks, 
compact bone ingrowth was observed throughout the scaffolds 
in both Ti-only (Figure 7c) and Ti/Ag (Figure 7d) scaffolds in 
close apposition to the struts.
2.8. X-ray Microtomographic (XMT) Analysis of Scaffolds In Vivo
The percentage of bone ingrowth (BI) at 12 weeks and statistical 
significances for these values are presented in Figure 8. Postim-
plantation, Ti or Ti/Ag scaffolds appear well incorporated into 
2.5 mm defects in rat tibiae at all timepoints, demonstrating 
robust bone ingrowth. A conspicuous amount of bone ingrowth 
is observed between 2 and 12 weeks. At 12 weeks postimplan-
tation, Ti (Figure 8a-i) and Ti/Ag groups (Figure 8a-ii) have a 
similar amount of BI, as confirmed by micro-CT quantification 
(Figure 8b). These results demonstrate that the nanolayer silver 
coating does not cause a marked unfavorable response in the 
volume of newly regenerated bone.
3. Discussion
Titanium and titanium alloys are the most widely chosen bio-
material for orthopedic implants due to their intrinsic proper-
ties: these include lightness, high compressive/tensile strength, 
and biocompatibility. These materials are also compatible with 
rapid 3D manufacturing techniques such as SLM. Due to the 
large numbers of joint replacements carried out worldwide, 
implant failure as a result of osteolytic infection, which consti-
tutes around 2% of all procedures, poses a serious postsurgical 
issue.[4,2] Consequently, there is an urgent need to find a trans-
latable, reliable method of surface modification for titanium 
orthopedic materials that can reduce surface colonization, 
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Figure 6. Scanning electron microscopy revealed conspicuous mineralized, hemitubular 
structures (arrowheads) attached to the surface of a Ti/Ag-coated foam scaffold implanted 
for 2 weeks in a rat tibia. At higher magnification (inset from boxed area; bar = 5 µm), one 
of these structures exhibits aligned and mineralized fiber bundles (arrows) within concentric 
lamellae; structures that are consistent with formation of an early Haversian system directly 
on the material.
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while preserving their osteoconductive properties.[33,34,59] One 
approach explored to reduce bacterial colonization and prolif-
eration is the introduction of metallic elements to modify the 
surface of biomaterials. A variety of metals have been explored 
in this field, including zinc,[35] strontium,[36] gallium,[59] 
and gold/palladium[37] although silver is the most widely 
employed metal coating on materials surfaces due to its antimi-
crobial properties and the susceptibility of multidrug resistant 
bacterial strains to silver.[9,33]
In terms of antimicrobial coatings on bone implants, ALD 
offers the prospect of producing ultrathin, highly conformal 
coatings on all wettable surfaces of the implant.[28,38] One of 
the key advantages of using ALD to coat the implants is that 
under appropriate conditions, it proceeds via saturative steps, 
resulting in self-limiting film growth. This means that ALD 
can give truly atomic scale control of the deposition process 
and can produce ultrathin films with excellent uniformity and 
conformity, even on complex high aspect ratio 3D structures.[39] 
The coating we describe in this study is so thin that the total 
quantity of active material is kept to a minimum (below levels 
of detection by ICP-MS in our study), which helps to reduce 
concern relating to systemic toxicity of nanolayer silver-coated 
orthopedic implants.[40,41]
The majority of studies examining the antimicrobial poten-
tial of silver for dental/orthopedic applications rely on dis-
solution of Ag particles from either cements[9,42] or surface 
coatings[36,41,43,44] for titanium. These studies generally report a 
>2 log-fold increase in microbicidal activity, although silver par-
ticles are highly mobile and potentially toxic, with their tissue 
accumulation characteristics being largely unexplored.[40,41] 
Investigation of silver-nanoparticle films that are bonded to tita-
nium is therefore of great interest as a method for reduction of 
postsurgical osteolytic infections, while preventing the release 
of potentially toxic quantities of silver. Metallic silver is inert 
in the body but has been demonstrated to ionize to the Ag+ 
active form in the presence of moisture and body fluids, where-
upon it binds to bacterial cell walls leading to cell death.[22] The 
mechanism of action of these Ag+ ions has been linked to their 
interaction with thiol (sulfhydryl) groups. However, other target 
sites principally on the bacterial cell wall may be involved in 
the microbicidal activity of Ag[24] and Cu[45] by rupturing cell 
membranes and generating reactive oxygen species. The ability 
of Ag+[17] or Cu2+ ions to exert a microbicidal effect similar to 
the biofilm reduction and growth inhibition we describe is 
dependent on the lability of the complexed metal. The majority 
of approaches for dissolution of Ag+ or Cu ions for antimicro-
bial applications is directed toward localized release via gradual 
solubilization. Although localized release of Ag-nanoparticles 
via dissolution achieves excellent antimicrobial effects in 
vitro[9,42] and in vivo,[41,43,46] this approach is associated with 
increased silver levels in both serum and systemic organs in 
addition to evidence of toxicity.
Our results conclusively demonstrate that conformal nano-
textured silver films, which are bonded to the titanium, reduce 
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Figure 7. Light microscopic images of hematoxylin and eosin stained (50–100 mm thick) transverse sections from rat tibiae sampled at a,b) 2 or b,d) 
12 weeks after implantation with either a,c) titanium or b,d) nanolayer silver-coated titanium. At 2 weeks, clear evidence of early bone deposition and 
dense connective tissue is seen surrounding the implants (between the black arrowheads). By 12 weeks, there is a high proportion of bone within 
the lesion and it is in close apposition to the struts in both types of implant. Ti, titanium only; Ti/Ag, nanolayer-coated titanium; BM, bone marrow. 
Monofilament suture used to secure muscle layers over implant (white arrows in a).
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the growth of the osteolytic pathogen S. epidermidis on the 
surface of Ti/Ag scaffolds by over 2 log-fold. However, this 
response was organism specific, as MRSA growth while gener-
ally slow on Ti-only scaffolds (and similar to growth of S. epider-
midis on Ti/Ag scaffolds) was not further inhibited by incuba-
tion on Ti/Ag scaffolds. This observation is consistent with that 
reported for Ag coatings of endotracheal tubes where MRSA 
growth is also not inhibited (in comparison to uncoated sam-
ples) over a period of 5 d.[47]
Similar to the results we report for nanolayer ALD-coated 
titanium implants, there is robust in vitro growth and differ-
entiation of osteogenic cells (including mesenchymal stem 
cells, osteoblasts, and osteoclasts) on scaffold surfaces coated 
with either silver or silver composites.[14,30,31] More specifically, 
we examined the growth of SAOS-2 cells (an osteoblasts-like 
human cell line) on scaffolds between 6 and 48 h following cul-
ture and show ultrastructural evidence of cell survival and adher-
ence, in addition to an MTT assay confirming cell population 
viability on both Ti-only and Ti/Ag scaffolds. Our findings are 
consistent with both human SAOS-2 cell and mouse osteoblast 
cells (MC3T3-E1)[43,48] grown on silver-nanoparticle-coated tita-
nium surfaces.[59] However, in vitro responses can be cell type 
specific as high concentrations of labile Ag-containing surface 
coatings are known to be toxic to human fetal osteoblasts.[49] 
We also found that both attachment and growth of HDMEC is 
well tolerated on Ag-coated surfaces, similar to that described 
for human umbilical vein endothelial cells grown on silver-
doped ceramic nanopowder.[50] In a mouse model where higher 
concentrations of Ag-nanoparticles are released into the micro-
circulation, significant toxicity on endothelium has also been 
reported.[51] We also observed that two other human cell lines 
(Hs27 and HaCaT; data not shown) show robust cell growth on 
Ti/Ag scaffolds, consistent with observations that growth of a 
variety of cell types[52] on titanium surfaces coated with various 
silver compositions is supported.
The in vivo studies are the first to document the relationship 
between pre-existing bone, neovascularization (new blood vessel 
growth), osteogenesis, and remodeling during the 12 week time 
frame of a solid uncoated or ALD-nanolayer-coated implant. 
These unique observations on SEM of vascular casts of tibial 
samples show robust new capillary formation by 2 weeks post-
implantation, particularly around the struts of the scaffolds, with 
numerous small caliber vessels emerging from the surrounding 
periosteum and forming irregular interconnected networks. The 
presence of numerous highly branched capillaries emerging 
from pre-existing vessels is a well-recognized process in the cor-
tical bone regeneration process,[53,54] however, we are unaware 
of their demonstration in the context of solid (particularly tita-
nium) implants. These capillary networks precede mature bone 
ingrowth into the scaffolds at 2 weeks and are most likely associ-
ated with the significant increase in gene expression associated 
with implantation of roughened titanium surfaces.[55]
We also detail the first ultrastructural evidence for de novo 
formation of Haversian systems directly on the surface of a 
2 week postimplantation Ti/Ag scaffold; similar to a report in 
which Sr/Ag-doped nanotubules induce osteogenesis in vivo.[36] 
Porous scaffolds with roughened surfaces (similar to both 
Ti-only and Ti/Ag implants described in our study) provide 
morphology similar to trabecular bone, to which osteoblasts can 
attach in vitro and in vivo, differentiate and deposit matrix that 
will eventually mineralize and begin the formation of woven 
bone.[56] By 12 weeks’ postimplantation, there is clear evidence 
of bone and vascular remodeling within the porous structure of 
Ti-only and Ti/Ag scaffolds, including Volkmann’s canals with 
attendant capillaries—features that are characteristic of mature 
bone growth.[54,57] In addition, 2D light microscopic examination 
of thick histological sections and 3D X-ray computed microto-
mographic reconstructions revealed excellent bone ingrowth in 
both Ti-only and Ti/Ag scaffolds, similar to that described for 
rats implanted with titanium coated with either silver-oxide-
doped hydroxyapatite[43] or silver-impregnated nanotubes.[17]
4. Conclusion
We have demonstrated the SLM manufacture of bespoke 
of titanium scaffolds, which have been coated by the ALD 
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Figure 8. a) Representative micro-CT images of uncoated (Ti) and silver-
coated titanium scaffold (TiAg) at 2, 6, and 12 weeks postimplanta-
tion. At 12 weeks postimplantation, inset histology image (i, ii) shows 
comparable amount of newly formed bone ingrowth in both groups 
(NS; p > 0.05), as confirmed by quantitative study of b) micro-CT data. Ti, 
titanium insert, NB, new bone; HB, host bone; Bar = 1 mm.
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process with a uniform, conformal nanolayer of silver. Silver-
nanoparticle-coated SLM titanium scaffolds induce a 2-log fold 
reduction in surface growth of a major osteolytic pathogen 
by (S. epidermidis), as well as supporting robust growth and 
differentiation of human cell lines important for bone regen-
eration. In addition, we show for the first time that titanium 
implants coated with a silver nanolayer (≈40 nm) induce 
robust osteogenesis and angiogenesis in vivo, with no evi-
dence of the systemic toxicity that is commonly associated 
with thicker coatings. Our results highlight the considerable 
benefits of ALD nanolayer silver-coated titanium implants 
warranting their further investigation for use in clinical ortho-
pedic applications.
5. Experimental Section
Preparation of Nanolayer-Coated Titanium Scaffolds—Selective Laser 
Melting of Bespoke Titanium Solids and Foams: All of the SLM parts in 
this work were fabricated on a SLM Realizer 2 – 250 (MCP, Germany), 
using Realizer software (Realizer, GmbH, Borchen, Germany) for the 
manipulation of CAD files. Before starting the SLM manufacturing 
process, the chamber was flushed with Argon gas until the oxygen level 
was below 250 ppm. The oxygen level was determined using a Rapidox 
2100 gas analyzer (Cambridge Sensotec Ltd., St Ives, UK). The flushing 
was stopped once the oxygen was below 250 ppm and the build process 
was then started. The feedstock for SLM was grade 1 commercially pure 
titanium powder, which was produced by a gas atomization process 
(Sumitomo, Japan). The feedstock had a modal particle diameter of 
28.5 µm, with 90% of the particles being under 45 µm.
For the SLM of porous structures, the powder layer thickness 
was set at 50 µm, the laser beam diameter was 80 µm and the laser 
power and exposure were set to produce melt spots with a nominal 
diameter 180 µm. These parameters enabled the generation of porous 
“wire frame” structures with a nominal porosity of 65%. For the solid 
structures, the scanning strategy created the outer circular profile first 
and then filling in with hatch lines, which alternated between alignment 
in the x-direction for one build layer and alignment in the y-direction 
for the next build layer. A laser beam diameter of 80 µm with a point 
distance (the separation of adjacent hatch lines of 70 µm was used). The 
profiles were formed using 95 W of laser power with 700 µs exposures 
for the profiles, while the hatch pattern was formed using 165 W of laser 
power with 600 µs exposures.
Following manufacture, scaffolds were cleaned (to remove residual 
organic solvents and unsintered powder): samples were immersed in 
5% micro-90 detergent (Decon, Sussex, UK) in distilled water at 60 °C 
and sonicated for 90 min using an ultrasonic bath (VWR, Radnor, USA). 
Samples were then rinsed again prior to sonication in distilled water at 
70 °C for a further 90 min before a final rinse in fresh distilled water. The 
structures were then dried at 80 °C in an oven before being sintered at 
1400 °C for 3 h in a VFS HEQ 2624 vacuum furnace (Philadelphia, USA) 
at a pressure of 5 Torr to increase compressive strength and reduce the 
quantity of incipiently melted powder particles. Prior to ALD, sintered 
solid and porous structures were cleaned again by repeating the process 
described above. To ensure consistency in scaffolds used throughout 
the experiments described in this study, 2400 samples were fabricated 
in a single batch (1200 solid and 1200 foam structures) and used for all 
subsequent experiments described in this study.
Preparation of Nanolayer-Coated Titanium Scaffolds—Atomic Layer 
Deposition of Silver: Silver was deposited on half the total number of 
solid and porous implants by direct liquid injection ALD using an Aixtron 
AIX200FE reactor, which was customized as described in ref. [58]. The 
self-limiting ALD process used for the deposition of silver has previously 
been reported.[28] A 0.1 molar solution of (hexafluoroacetylacetonato)
silver(I)(1,5-cyclooctadiene) (hfac)Ag(1,5-COD) (SAFC Hitech, 
Bromborough, UK) in anhydrous toluene (Sigma-Aldrich, Germany) 
was used as the silver source. Hig performance liquid chromatography 
(HPLC) grade Propan-1-ol (Fisher, Leics, UK) was use as a coreactant 
and was delivered into the reactor using a conventional vapor-draw 
source held at room temperature (≈20 °C). During each ALD cycle, 
(hfac)Ag(1,5-COD) solution was introduced into the reactor for 4 s at a 
rate of 17.5 µL s−1 and was volatilized using a vaporizer set to 130 °C. 
The vapor was transported from the vaporizer into the reactor chamber 
using 200 sccm of argon (99.999%; BOC, UK) carrier gas. The coreactant 
was introduced directly into the reactor for 4 s via a Swagelok ALD valve. 
During each ALD cycle, the two reactants were sequential pulses into 
the reactor with 8 s gas purges between them to prevent reactions in the 
gas phase. To coat the SLM titanium implants, samples were mounted 
in a custom-made titanium holder and the ALD sequence was repeated 
500 times. To ensure that growth on the implant structures proceeded 
in a self-limiting fashion, the reactor temperature was adjusted slightly 
until a low mass thermocouple attached to the top of one of the 
implants read 125 °C (the midpoint of the self-limiting ALD temperature 
window).[28]
The microstructure and morphology of the silver films were 
investigated using XRD and SEM. XRD was carried out on silver films 
deposited on Si(100) wafers (virgin test grade supplied by Compart 
Technology Ltd., Tamworth, UK) using a Bragg-Brentano diffractometer 
with a Copper Kα X-ray source (Rigaku miniflex, Tokyo, Japan). Although 
titanium foils can be used for XRD, silicon was selected for this purpose 
as it avoids substrate related diffraction peaks in the region of interest, 
which partially obscures the silver diffraction peaks. SEM of silver 
deposited onto the titanium structures was carried out using a field 
emission gun scanning electrom microscope (JEOL JSM-7001F, Tokyo, 
Japan). Film composition was determined using EDX spectroscopy 
on coated implants as well as XPS on flat titanium witness samples. 
EDX was carried out using an INCA x-act detector (x-act-51-ADD0001, 
Oxford Instruments plc, Abingdon, UK) attached to the FEG–SEM. XPS 
measurements were carried using a FISONS VG Escalab MKII with 
an aluminum Kα X-ray source (1486.6 eV). Mass gain measurements 
were used to estimate the quantity of silver deposited during the ALD 
process. Mass gain per unit area was estimated by measuring the mass 
of flat titanium witness samples using a high precision analytical balance 
(Mettler Toledo XS-205-DU) before and after film deposition.
Preparation of Nanolayer-Coated Titanium Scaffolds—Sterilization of 
Solid and Porous Titanium Implants: Before use in biological assays, all 
samples were sterilized by immersion in 200 µL of 70% ethanol (Fisher 
Scientific UK Ltd, Loughborough, UK) for 2 h. The ethanol was then 
removed and the samples were exposed to UV radiation for 30 min 
on each side of implant) in a Class II biological safety cabinet; method 
adapted from ref. [59]
Microbiology—Bacterial Strains and Culturing: The provenance of 
osteolytic strains of both S. epidermidis (ATCC 35983[60]) as well as MRSA 
(S. aureus ATCC 43300) was confirmed by a universal 16S rRNA PCR 
protocol,[61] followed by DNA sequencing and confirmation of identity 
using the BLAST sequence algorithm[62] within the NCBI database. These 
organisms were grown at 37 °C under aerobic conditions on either 
tryptone soya agar or in tryptone soya broth (both from Oxoid Ltd., 
Hampshire, UK) with shaking at 150 rpm. A calibration graph for both 
microorganisms was constructed by means of dilution series plating 
of cultures at regular points throughout growth and then plotting cfu 
mL−1 versus OD660. This calibration was repeated in triplicate and for 
experimental purposes, a final loading of ≈1 × 103 cells per scaffold was 
used via serial dilution of fresh cultures in tryptic soy broth (TSB). Cell 
loadings in these experiments were confirmed and verified using dilution 
plate counts.
Microbiology—Assessing Bacterial Biofilm Formation on Solid Titanium 
Implants: To seed S. epidermidis onto solid titanium implants, an 
overnight culture was serially diluted to a final concentration of 
5 × 105 cells mL−1, and 2 µL of this suspension was applied to the surfaces 
of either the control titanium (Ti-only) or ALD prepared nanolayer silver 
scaffolds (Ti/Ag; a nominal coating thickness of ≈13 nm) solid titanium 
scaffold, which were located in a 96-well culture plate. The samples were 
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then incubated overnight at 4 °C to allow bacterial attachment, and 
the following day 100 µL of fresh TSB broth was gently added to avoid 
shear stress on the organisms. The samples (n = 6 replicates per group) 
were then further incubated at 37 °C for 96 h. Microbial biofilms were 
assessed by the widely employed crystal violet staining method. Briefly, 
Ti scaffolds were recovered and following washing in distilled water, the 
implants were then allowed to dry at room temperature overnight prior 
to being stained with 1% CV (Sigma-Aldrich, UK) in water for 45 min. 
The excess dye was removed by washing the implants with distilled 
water. Elution of crystal violet stain was performed by adding a 150 µL 
volume of 95% ethanol with shaking, to dislodge the attached cells. 
The implant was removed prior to measuring the absorbance of the 
solubilized crystal violet at OD595 in a spectrophotometric plate reader 
(Flurostar Omega: BMG Labtech). All experiments were repeated three 
times and a single representative data set presented.
Microbiology—Bacterial Recovery from Titanium Scaffolds: Unless 
otherwise indicated, all materials were purchased from Sigma-Aldrich, 
UK. Total bacterial counts were used to estimate the number of viable 
organisms remaining on the implants. After 96 h, implants with 
adherent bacteria were gently washed in sterile phosphate buffered 
saline (PBS) and transferred into a 1.5 mL microcentifuge tube. A 1 mL 
volume of sterile of Ringers’ solution (Oxoid Ltd., Hampshire, UK) was 
added to the sample and the bacteria were recovered by vortex mixing 
for 5 min. Following bacterial recovery, the washed implants were then 
stained with 1% (w/v) crystal violet (as above) to assess the numbers 
of organisms remaining on the implants. The recovered viable bacteria 
in Ringers’ were enumerated by serial dilution on Tryptone soya agar 
plates. The plates were subsequently incubated for 24 h at 37 °C and the 
colonies counted.
Cell Culture—Seeding Cells on Implants: Solid implants were immersed 
in 1 mL of serum free Dulbecco’s Modified Eagle’s Medium (DMEM) 
media and subsequently vacuum processed at 10 psi for 15 min to 
remove air bubbles and wet the entire implant surface. The implants 
were then incubated in a humidified incubator at 37 °C with 5% CO2 
for a further 3 d in DMEM media supplemented with 10% fetal bovine 
serum (FBS; both from Gibco, UK).
Prior to seeding cells on the implants, SAOS-2 (osteoblast-like), 
HDMEC (endothelial), HaCaT (keratinocyte), and Hs27 (fibroblast) cells 
were cultured in media consisting of DMEM supplemented with 10% 
heat-inactivated FBS and maintained in a humidified incubator at 37 °C 
and 5% CO2. A total of 2 µL of cell suspension containing 5 × 103 cells 
were pipetted onto the surface and the implants further incubated for 
30 min to allow cells to adhere to the scaffold surface. To avoid shear 
stress on the adherent cells, 400 µL of prewarmed media (DMEM with 
10% FBS) was gently added to the culture plate. The implants were then 
incubated for either 6, 24, or 48 h (n = 4 per group) before preparation 
for ultrastructural analyses.
In Vivo Model of Bone Regeneration: The animal experiments 
described in this study were approved by both the local animal care 
committee (Ulster University) as well as national authority (UK Home 
Office) and were carried out in strict adherence to guidelines for the 
use of experimental animals. In brief, a group of 10–12 week old male 
Wistar rats (300–400 g body weight) were appropriately anesthetized 
and prepared for surgery, prior to drilling a 2.5 mm diameter subcritical 
defect in the mid shaft of the medial face of right tibia as previously 
described.[63,64] During surgery, rats were randomly assigned to receive 
either a single Ti or Ti–Ag scaffold (12 per group) and the implant was 
press fitted into the defect. Animals were euthanized at either 1, 2, 3, 4, 
6, or 12 weeks after surgery.
In Vivo Detection of Ag Using ICP-MS: The rats implanted with either 
Ti-only or Ti/Ag foams in the tibia (see above) were left for 12 weeks 
and following euthanasia, livers harvested to determine the quantity of 
accumulated silver by ICP-MS. In preparation for determination of free 
silver content, 250 mg of bovine liver (as a control) and 500 mg rat 
liver were freeze-dried and powdered prior to mixing in a final volume 
of 50 mL in double-distilled water. The tissues were then digested by 
microwaving: each sample was placed in a digest tube to which 4 mL 
of HNO3 and 1 mL of H2O2 were added, before being microwaved for 
120 s. A 1 mL volume of concentrated HCl was then added to each tube. 
The contents of the digest tubes were decanted into a 50 mL tubes and 
samples were autoloaded and analyzed for Ag concentration using an 
Elan 6100 ICP-MS equipment (Perkin-Elmer SCIEX, Norwalk, CT, USA). 
This was calibrated using Aristar ICP-MS multielement standards and 
single element standards (Merck BDH), diluted in 3.5% v/v HNO3 
and 0.5% v/v HF. Blanks, Ag-spiked samples, and bovine liver were 
used reference points and standards in addition to the normal ICP-MS 
standard operating procedure standards.
X-Ray Computed Microtomography: For the 2, 6, and 12 weeks 
postsurgical samples, the tibiae from rats with either Ti-only or 
Ti/Ag implants were harvested, immersed in 10% buffered formal 
saline solution and dissected for micro-CT (µCT) scanning as previously 
described.[64] An 85 kV, 111 µA source current was employed in the 
experiment and a total of 1000 projections were acquired. X-rays were 
filtered using a 0.5 mm thick copper filter to minimize beam-hardening 
effects. The scans were reconstructed using commercial software 
(Datos|x rec, Phoenix|X-ray General Electric Company, Measurement 
and Control) according to the manufacturer’s instructions. The 
reconstructed images were visualized using Avizo Image processing 
software (Visualisation Sciences Group, Merignac Cedex, France). The 
defect region was identified and bone ingrowth quantified, using an 
in-house algorithm as described in ref. [63] The percentage of bone 
ingrowth was calculated for the 12 week samples (n = 6 for each group) 
to investigate the biological effect of silver coating at the end point of 
the experiment.
X-Ray Computed Microtomography—Histology: Following XMT, 
the tibial samples were decalcified in a solution of 14% 
ethylenediaminetetraacetic acid (EDTA; Sigma-Aldrich, Dorset, UK) in 
PBS (pH 7.4), with the EDTA being changed every 2–3 d for 3 weeks. 
The samples were then processed for embedding in LR white (TAAB 
Laboratories Equipment Ltd, Berks, UK); in brief, samples were 
successively dehydrated in two changes of 70% ethanol (overnight), 
two changes of 80% ethanol (1.5 h each), 2 changes of 90% ethanol 
(1.5 h each) and 3 changes of 100% ethanol (twice for 1.5 h each and 
one overnight). Samples were then infiltrated with a mixture of 50% 
ethanol/50% LR white (TAAB Laboratories Equipment Ltd., Berks, 
UK) overnight, followed by infiltration with 100% LR white for 24 h. To 
initiate hardening of the resin, 20 µL of accelerator (TAAB Laboratories 
Equipment Ltd, Berks, UK) was added to 10 mL LR white and the tibial 
sample was critically orientated in a clear base mold (Surgipath, Leica, 
Milton Keynes, UK) prior to polymerization at 4 °C for 2 h. Excess 
resin was ground from the sample and the trimmed blocks were glued 
onto plastic microscope slides (EXAKT, Oklahoma City, USA) with 
Krazy Glue (Westerville, USA) and UV treated for 5 min using a EXAKT 
vacuum adhesive press (EXAKT, Oklahoma City, Oklahoma, USA). 
Samples were cut ≈1 mm from the center of the titanium scaffold 
using a diamond band cutter and subsequently ground with K400, 
K1200, and K4000 grinding paper (all from EXAKT, Oklahoma City, 
USA) to yield 50–100 µm thick sections for staining and microscopic 
evaluation.
Sections were stained with Gill’s hematoxylin as follows: sections 
were placed in 1% formic acid (Sigma-Aldrich, Dorset, UK) for 10 min, 
rinsed in absolute ethanol for 5 min, and rinsed in deionized water for 
2 min. Hematoxylin solution (Sigma-Aldrich, Dorset, UK) was applied 
dropwise onto the section, allowed to stain for 30 min and then sections 
were thoroughly rinsed in tap water. Multiple stain solution (Polysciences 
Inc., Warrington, USA) was added for 20 min followed by another rinse 
in tap water and air drying. Stained samples were then examined on a 
Zeiss Axiophot microscope (Zeiss; Wetzlar, Germany) at a range of 
objective magnifications.
Vascular Casting: To examine vascular ingrowth into the titanium 
scaffolds, a number of rats were injected intraperitoneally with 
2400 U kg−1 body weight of porcine heparin (Sigma-Aldrich, UK) 30 min 
before the casting procedure to inhibit clotting in the microvasculature. 
Prior to perfusion, animals were anesthetized with a mixture of Ketamine 
and Xylazine as described above. After confirmation of a deep plane of 
anesthesia, an incision was made in the midline of the abdomen and the 
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descending aorta exposed and tied off proximally. A catheter was inserted 
into the descending aorta secured using 4-0 Ethicon Ethilon polyamide 
(Johnson & Johnson, New Brunswick, New Jersey, USA) and, the inferior 
vena cava severed. The vasculature was flushed with 25 mL saline 
(warmed to 37 °C) followed by 25 mL of 2.5% PBS (pH 7.4) buffered 
glutaraldehyde warmed to 37 °C. Finally, a volume of 25 mL Pu4ii resin 
(vasQtec, Zurich, Switzerland) was injected into the circulation and the 
resin allowed to harden at room temperature overnight prior to storage 
at −20 °C. The tibiae were subsequently harvested from animals by 
careful dissection, immersed in tap water, and subsequently stored at 
−20 °C prior to maceration. Samples were macerated in 20 mL 20% 
NaOH (Fisher Scientific UK Limited, Leicestershire, UK) for 24 h with 
regular changes followed by extensive washing in distilled water a total 
of five times. Samples were left to dry at room temperature prior to 
preparation for SEM.
Preparation of Samples for SEM: Scaffolds either containing bacteria 
(following 96 h of incubation), those incubated with cells (6–48 h) or 
alternatively tibiae that had been appropriately macerated to remove 
all cellular material (2–12 weeks’ postsurgery; see above) were washed 
in sterile PBS and fixed in glutaraldehyde 2.5% in 0.1 M sodium–
cacodylate buffer (pH7.4) either overnight or until processing for 
SEM. The samples were then washed gently three times (for 10 min 
each) in 1 mL of 0.1 M sodium–cacodylate buffer and dehydrated in 
ascending grades of ethanol (25%, 50%, 75%, 95%, and 100%; 
Sigma, UK). Following dehydration, samples were then immersed in 
hexameythldisilazane (Sigma, UK) for 10 min, before removal, air drying 
and subsequent mounting on aluminum stubs. Prior to ultrastructural 
examination, samples were sputter coated with gold-palladium (Polar 
ES100; set at 18 mA for 240 s) and imaged with a scanning electron 
microscope (JEOL; Japan) at accelerating voltage of 10kV and a spot size 
of 25 µm.
Statistical Analyses: For each microbiological (n = 6 replicates; 
experiment repeated three times) or cell culture assay (n = 4; no 
repeats); individual representative experiments are shown in the results 
section. All data sets were analyzed with the aid of GraphPad Prism6 
software (Intuitive Software for Science, San Diego, USA). Results are 
expressed as mean ± standard error. Significance was determined using 
Independent two-tailed t-tests for group comparisons, with p < 0.05 
considered significant.
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